Sudan I/KLH is an antigen-adjuvant conjugate of Sudan I and keyhole limpet hemocyanin (KLH). Conjugating the antigen with a protein adjuvant enhances the production of antigen-specific antibodies in vaccine models. The conjugate does not disrupt protein folding or alter major epitopes, and it boosts cross-presentation and generation of antigen-specific T cells.